NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE237592 Query DataSets for GSE237592
Status Public on Apr 03, 2024
Title Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer
Organism Mus musculus
Experiment type Other
Summary Keap1 mutant lung tumors were injected into mice and once lung tumors formed the mice were treated with anti-PD1, DRP-104, or the combination of the drugs. Immune cells and tumor cells were isolated from the lungs and ExCITE-seq was performed.
 
Overall design 2 mice (G1 vs G2) per treatment arm: Isotype + Vehicle (HT4), DRP-104 + Isotype (HT2), anti-PD1 + Vehicle (HT3), and DRP-104 + anti-PD1 (HT1). After 5 days of treatment, immune and tumor cells were analyzed by ExCITE-seq with libraries for gene expression, ADT, and TCR
 
Contributor(s) Pillai R, LeBoeuf S, Hao Y, Tsirigos A, Koralov S, Papagiannakopoulos T
Citation(s) 38536921
Submission date Jul 17, 2023
Last update date Apr 04, 2024
Contact name Alireza Khodadadi-Jamayran
Organization name New York University, NYU Langone Medical Center
Department Division of Advanced Research Technologies (DART)
Lab Applied Bioinformatics Laboratories (ABL)
Street address 550 1st Ave, MSB 304
City New York City
State/province NY
ZIP/Postal code 10016
Country USA
 
Platforms (1)
GPL21103 Illumina HiSeq 4000 (Mus musculus)
Samples (2)
GSM7634471 G1
GSM7634472 G2
Relations
BioProject PRJNA995781

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE237592_RAW.tar 216.2 Mb (http)(custom) TAR (of CSV, MTX, TSV)
GSE237592_README.txt 839 b (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap